New AI tools could screen existing CT scans to asses risk for heart disease. But, who'll pay for it, and will it improve ...

These sides aren't talking to each other. And there's a lot riding on it”: the podcast trying to bridge MAHA and public ...

His repeated ER visits weren’t about individual failure; they reflected structural barriers — transportation, access, work ...

Former Sen. Ben Sasse gives a glimpse of what it's like to be a participant in an tough but promising new drug for pancreatic ...

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

The FDA told more than 2,200 companies and researchers that they are required to report clinical trial results, or they may ...

Yesterday, we got highly promising results from a trial of Revolution Medicines’ pancreatic cancer pill, showing that ...

The director of WHO's Eastern Mediterranean region is weighing whether to run to be the next director-general at a time of ...

Hospitals offer their own chatbots, Medicare's ACCESS pilot, and an update Utah's 'AI doctor' experiment.

An experimental Medicare program, how family dynamics affect brain recovery, and other health news from Morning Rounds ...

Dana-Farber CEO Benjamin Ebert has no shortage of ideas and vision for the cancer institute as it untangles from Mass General ...

The board will now oversee a process to lower the cost of the type 2 diabetes medicine Jardiance by January 2027.